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The Duke treadmill score with
bicycle ergometer: Exercise capacity
is the most important predictor of
cardiovascular mortality
Esko Salokari1, Jari A Laukkanen2,3,4, Terho Lehtimaki5,
Sudhir Kurl2, Setor Kunutsor6, Francesco Zaccardi7, Jari Viik8,
Rami Lehtinen9, Kjell Nikus10, Tiit Ko¨o¨bi11, Va¨ino¨ Turjanmaa12,
Mika Ka¨ho¨nen11 and Tuomo Nieminen13,14
Abstract
Background: The Duke treadmill score, a widely used treadmill testing tool, is a weighted index combining exercise
time or capacity, maximum ST-segment deviation and exercise-induced angina. No previous studies have investigated
whether the Duke treadmill score and its individual components based on bicycle exercise testing predict cardiovascular
death.
Design: Two populations with a standard bicycle testing were used: 3936 patients referred for exercise testing (2371
men, age 56 13 years) from the Finnish Cardiovascular Study (FINCAVAS) and a population-based sample of 2683 men
(age 53 5.1 years) from the Kuopio Ischaemic Heart Disease study (KIHD).
Methods: Cox regression was applied for risk prediction with cardiovascular mortality as the primary endpoint.
Results: In FINCAVAS, during a median 6.3-year (interquartile range (IQR) 4.5–8.2) follow-up period, 180 patients
(4.6%) experienced cardiovascular mortality. In KIHD, 562 patients (21.0%) died from cardiovascular causes during the
median follow-up of 24.1 (IQR 18.0–26.2) years. The Duke treadmill score was associated with cardiovascular mortality
in both populations (FINCAVAS, adjusted hazard ratio (HR) 3.15 for highest vs. lowest Duke treadmill score tertile, 95%
confidence interval (CI) 1.83–5.42, P< 0.001; KIHD, adjusted HR 1.71, 95% CI 1.34–2.18, P< 0.001). However, after
progressive adjustment for the Duke treadmill score components, the score was not associated with cardiovascular
mortality in either study population, as exercise capacity in metabolic equivalents of task was the dominant harbinger of
poor prognosis.
Conclusions: The Duke treadmill score is associated with cardiovascular mortality among patients who have undergone
bicycle exercise testing, but metabolic equivalents of task, a component of the Duke treadmill score, proved to be a
superior predictor.
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Introduction
Although other modalities have partially replaced clin-
ical exercise test as a diagnostic tool for assessment of
coronary artery disease (CAD), the test has become
more vital in evaluating prognosis and focusing avail-
able treatments for high-risk patients.1,2 One of the
most widely studied and used prognostic variables in
exercise testing is the Duke treadmill score (DTS),
which is a weighted index combining treadmill exercise
time with standard Bruce protocol, maximum ST-seg-
ment deviation on electrocardiogram (ECG) and exer-
cise-induced angina.3 The score was initially developed
to add prognostic information to that provided by clin-
ical data, coronary anatomy and left ventricular ejec-
tion fraction in patients with suspected CAD referred
for catheterisation.3 The DTS was later also validated
for patients with suspected CAD,4 and it is still in clin-
ical use for risk stratiﬁcation for these patients.5,6
Interestingly, prior studies have not properly tested
whether the DTS is a superior prognostic marker in
comparison with its components.
As exercise time of the Bruce protocol can be
replaced with metabolic equivalents of tasks (METs),
the DTS is also suitable for other exercise test proto-
cols.7 In many European countries, a bicycle ergometer
rather than a treadmill is the preferred testing modality.
However, the prognostic value of the DTS using the
standard bicycle exercise testing has not yet been inves-
tigated. Thus the purpose of this study was to assess the
prognostic value of the DTS in bicycle exercise testing.
Combined analysis of several parameters is commonly
used to simplify risk assessment; however, the combin-
ation needs to be superior to an independent assess-
ment of each variable. Therefore, we also compared
the prognostic capability of the DTS to that of its com-
ponents. We hypothesise that the DTS is a useful prog-
nostic marker of cardiovascular death, superior to its
components, in the exercise test performed with a
bicycle ergometer.
Methods
Study cohorts
We used two independent data cohorts. In the Finnish
Cardiovascular Study (FINCAVAS), all consecutive
patients referred for an exercise test at Tampere
University Hospital and willing to participate were
enrolled between October 2001 and December 2008.
A detailed description of the study has been published.8
A study population of 4178 patients (2537 men and
1641 women) was recruited. Data from a total of
3758 patients (2249 men and 1509 women) with tech-
nically successful exercise tests – including exercise
capacity and angina data as well as continuous digital
ECG with ST-segment deviation and slope data – were
analysed in the present study.
The main indications for exercise testing were a sus-
picion of CAD (47%), evaluation of work capacity
(27%), evaluation of arrhythmias (26%), adequacy of
CAD treatment (13%), as well as obtaining an exercise
test proﬁle prior to an invasive procedure (9%) or after
myocardial infarction (MI) (7%); some patients had
more than one indication. The ethics committee of
Tampere University Hospital district approved the
study protocol, and all patients gave informed consent
as stipulated in the Declaration of Helsinki.
The other dataset was from the Kuopio Ischaemic
Heart Disease (KIHD) risk factor study. This was a lon-
gitudinal population-based study designed to investigate
risk factors for cardiovascular diseases, atherosclerosis
and related outcomes. The baseline data consist of ran-
domly selected 2683 men between 42 and 61 years of age
living in the city of Kuopio and surrounding rural com-
munities in eastern Finland, of which 2392 men with
successful exercise test data were included in our study.
The baseline examinations were conducted between
March 1984 and December 1989. The KIHD study
has previously been described in detail.9
Study flow
FINCAVAS. In FINCAVAS, written informed consent,
medical history, resting and exercise ECGs and exercise
systolic and diastolic blood pressure recordings were
obtained, as previously described.8 In brief, prior to
the exercise test using a bicycle ergometer, subjects
lay down in the supine position for 10 minutes, and
the resting ECG was digitally recorded. The Mason–
Likar 12-lead system was used. The exercise tests were
intended to be maximal tests except for 7% of the tests,
which evaluated the status after an MI and applied a
heart rate limit of 120–130 beats/min; even those were
included in the analysis.
The initial workload of 20–30W was increased step-
wise by 10–30W every minute based on patient charac-
teristics. ECGs were digitally recorded at 500Hz with the
CardioSoft exercise system (version 4.14; GE Healthcare,
Freiburg, Germany). The reasons for termination of the
test were chest pain (5.7%), dyspnoea (12.8%), fatigue
(61.6%), ECG changes (1.4%), blood pressure changes
(1.5%) or other reasons (11.5%). The objective exercise
levels as deﬁned by the supervising physician were max-
imal in 76.4%, almost maximal in 18.7%, reasonable in
3.1% and poor in 0.6% of the tests.
KIHD. In the KIHD study, the patients underwent a
maximal symptom-limited exercise tolerance test using
an electrically braked cycle ergometer with increase in
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the workload of 20W/minute. Maximal exercise cap-
acity was calculated from VO2max, which was deﬁned
as the highest value or the plateau of directly measured
oxygen consumption using a respiratory gas analyser
(Mijnhardt and Medical Graphics, Minneapolis, MN,
USA). ECG was recorded continuously with the Kone
620 electrocardiograph (Kone, Turku, Finland). ECG
was printed at 30 second intervals during exercise and
at least 5 minutes of recovery while the subject was
sitting on the bicycle.9,10
The Duke treadmill score
FINCAVAS. The DTS was calculated as follows: exercise
time – (5max ST-segment depression) – (4Angina
index). The exercise time in minutes was approximated
from the maximal METs using a linear approach
derived from the scientiﬁc statement of the American
Heart Association regarding exercise standards for test-
ing and training.7 The following equation was used:
exercise time¼ (METs – 1)/1.044. METs were esti-
mated on the standardised basis of maximum workload
and patient weight, with 1 MET being equivalent to
3.5ml oxygen uptake/kg/min.
The original DTS used maximal ST-segment devi-
ation – whether depression or elevation – compared
to the resting phase from the lead with the most devi-
ation.3 We took into account only the maximal net
ST-segment depression (STD) because non-diagnostic
ST-segment elevation is rather common in healthy
people due to early repolarisation. ST-segments were
analysed with modiﬁed CASE/CardioSoft software
(V.1.84; GE Healthcare, Freiburg, Germany). The soft-
ware also calculates the ST slope on the basis of the
current median complex, measured over an interval
from the J point to the 1/8 of the average R-R interval
(a maximum of 80ms). This deﬁnition of slope takes into
account the correlation between heart rate and repolar-
isation time, avoiding the eﬀects of the T wave.11 The
STD and slope were calculated for the end of the resting
phase and for each minute of the exercise and recovery.
Possible ST-segment deviation at the resting phase was
extracted from the values during the exercise and recov-
ery to assess the diﬀerence caused by the exercise. If the
simultaneous ST-segment slope was at least 0.5mV/s,
the depression was set to zero, as up-sloping STD,
whether rapid or slow, might be associated with an
increased risk of future coronary events, but is not pre-
dictive for the presence of myocardial ischaemia in the
general population.12 The maximal STD in all the leads
except aVR was used in the analysis. If the maximal
STD was less than 1mm, it was set to zero, as it is not
considered pathological. Values greater than 5mm
(n¼ 34) were excluded from the data because they
were most likely due to measurement error.
The angina index has values of 0 (no exercise
induced ischaemic chest pain), 1 (non-exercise-limiting
angina) and 2 (exercise-limiting angina). To create the
angina index variable, we had to merge original
FINCAVAS variables. If the patient had no pain or
atypical pain during the exercise, the angina index has
the value 0. If the patient did not report possible
angina, but the clinician estimated the post-test
probability for CAD to be low, we also set the angina
index value to 0. If the patient had experienced typical
angina during the exercise, the angina index was 1
and if angina was the reason for ending the test, the
index was 2.
KIHD. Exercise time was calculated from the METs as
above.
In the KIHD study, maximal ST-segment deviation
from the baseline during exercise was recorded from
the leads V5 and aVF and the maximal value for ST-
segment deviation was used in the analyses. ST-segment
elevations were excluded, as well as depressions less
lthan 1mm and greater than 5mm. The ECGs were
also coded manually by an experienced cardiologist,
giving a variable for ischaemia values from 0 to 3, 0
meaning no ischaemia and 1–3 indicating the severity of
ischaemia. We factored in this variable so that our vari-
able for the maximal STD of the DTS would be as close
to that we used in the FINCAVAS population. If the
ischaemia variable had a value of 0, the maximal STD
variable was set to 0, and if the ischaemia variable had
values 1–3, the maximal STD variable was constituted
as above. This way we approximated that the ﬁnal ST-
variable takes into account the slope of the ST-segment.
If the patient had no angina, the DTS angina index
has a value 0, and if a patient had exercise-limiting
angina, the angina index has a value of 2. Non-limiting
angina was not taken into account in the original study
setting. The DTS was constituted as above from
FINCAVAS.
Originally, if the overall DTS is at least 5, the patient
is considered as ‘low risk’, a score between 11 and 5
denotes ‘moderate risk’, and a score of 11 or less indi-
cates ‘high risk’.3 Because only a limited number of
patients were classiﬁed as belonging to the high-risk
DTS category, we also divided the DTS into equal ter-
tiles taking account the whole population from two
cohorts.
Definition of comorbidities
The presence of CAD (no/yes) was taken from the med-
ical records and questionnaire (previous MI, angina
pectoris, revascularisation, and/or use of nitroglycerin).
Diabetes (no/yes) was deﬁned as having a clinical diag-
nosis and regular treatment with diet or medications.
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In the KIHD study, fasting plasma glucose of
7.0mmol/l or greater was an additional criterium.
Smoking (no/yes) was deﬁned as daily smoking
(FINCAVAS) or smoking within the past 30 days
(KIHD). The use of b-blockers was deﬁned as regular
use (no/yes). Some of the regular b-blocker users within
FINCAVAS were advised to pause the drug 3 days
before the test; those patients were classiﬁed in the
‘no’ category.
Ascertainment of follow-up events
Death certiﬁcates based on the 9th or 10th revision of
the International Classiﬁcation of Diseases (ICD-10)
were received from the causes of death register main-
tained by Statistics Finland;8,13 the data source has
been validated.14 The reviewers of death certiﬁcates
were blinded to events and test results. The deaths
were classiﬁed as cardiovascular when the ICD-10
code was I00–I79. Cardiovascular mortality was the
primary endpoint and all-cause mortality the secondary
endpoint. In FINCAVAS, the autopsy rate was 46%
for all deaths and 57% for patients who succumbed to
cardiovascular death. In the KIHD study the autopsy
rate was 80% for all deaths.
Statistical analysis
Diﬀerences between patient and exercise test character-
istics according to the DTS in tertiles were compared
using one-way analysis of variance, Kruskal–Wallis test
or chi-square test as appropriate.
The usefulness of the DTS in assessing the prognosis
was tested with a Cox proportional hazards model.
Covariates included age, sex, body mass index (BMI),
a diagnosed CAD, smoking status, b-blocker usage and
diabetes. The components of the DTS (STD, angina
index and performance in METs) were added to an
additional model with other covariates. The DTS was
entered as the original version categorised into three
parts (low risk, moderate risk and high risk) and as a
three-category version with tertiles.
Statistical analyses were performed using the SPSS
release 23.0 for Mac (SPSS Inc., Chicago, IL, USA).
All statistical tests were two-tailed and used an alpha
level of 0.05.
Results
Patient characteristics are given in Table 1. Within the
original DTS categorisation, 3.5% of patients of the
FINCAVAS population were classiﬁed as being in
high, 52% in moderate and 40% in low risk. In the
KIHD study population, only 1.6% were classiﬁed as
high, 31.4% as moderate and 67.0% as low-risk
patients. In our new categorisation a DTS over 6.7
belongs to the lowest risk tertile, scores from 3.0 to
6.7 to the middle tertile and scores below 3.0 to the
highest risk tertile.
FINCAVAS
The age of the population was 56 13 years. Death
from any cause or from cardiovascular causes was rec-
orded in 404 (10.3%) and 180 (4.6%) patients, respect-
ively, over the median follow-up period of 6.3 years
(interquartile range (IQR) 4.5–8.2).
As a three-category variable with the cut points from
the original treadmill studies, the DTS (highest vs.
lowest group) was highly predictive of both cardiovas-
cular death (HR 2.26, 95% CI 1.48–3.45, P< 0.001)
and all-cause mortality (HR 1.70, 95% CI 1.31–2.22,
P< 0.001) when adjusting for other covariates.
However, the prognostic signal of the DTS disappeared
entirely when the model was also adjusted with the
three components of the DTS (METs, angina index
and maximal STD): HR for cardiovascular death was
1.10 (95% CI 0.63–1.92, P¼ 0.740). Importantly, exer-
cise capacity in METs was the only DTS component
with a statistically signiﬁcant HR (0.77, 95% CI 0.70–
0.85, P< 0.001) in this fully adjusted model.
The results were similar for the DTS divided into
equal tertiles: the DTS was predictive of cardiovascular
death (HR 3.15, 95% CI 1.83–5.43, P< 0.001) and
all-cause death (HR 2.08, 95% CI 1.49–2.90,
P< 0.001). However, when adjusted with the three indi-
vidual components, the DTS was not predictive of
cardiovascular death and, again, METs was the
sole component linked with prognosis, as shown in
Table 2 and Figure 1.
KIHD
The age of the KIHD study population was 53 5.1
years. A total of 1200 deaths (44.7%) occurred from
any cause and 562 (21.0%) from cardiovascular causes
over the median follow-up period of 24.1 years (IQR
18.0–26.2 years).
As a traditional three-category variable and adjusted
with covariates, the DTS was predictive of cardiovas-
cular death and all-cause mortality when comparing
the lowest with the highest group (HR 1.52, 95% CI
1.25–1.85, P< 0.001 and 1.37, 95% CI 1.20–1.56,
P< 0.001, respectively). When also adjusted with all
three components of the DTS, the three-categorical
DTS was not associated with cardiovascular death
(HR 1.11, 95% CI 0.83–1.49, P¼ 0.48). Of the three
individual components, only exercise capacity in
METs was related to the risk of cardiovascular death
(HR 0.85, 95% CI 0.79–0.90, P< 0.001).
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When divided into equal tertiles, the DTS was pre-
dictive of cardiovascular death (adjusted HR 1.43, 95%
CI 1.13–1.80, P¼ 0.003) and all-cause death (HR 1.43,
95% CI 1.22–1.66, P< 0.000). However, when all com-
ponents of the DTS were included in the multivariable
model, only METs and maximal STD were statistically
signiﬁcant, as shown in Table 2 and Figure 1.
Discussion
Our ﬁndings demonstrate that the DTS based on the
bicycle ergometer test is consistently predictive of fatal
cardiovascular and all-cause mortality. The DTS was
predictive of cardiovascular death in both populations
as an original three-category variable. However, exer-
cise capacity alone proved to be a superior predictor
of outcomes in comparison to the DTS. One unit
increment in exercise capacity (METs) was related to
a 17–20% lower risk of cardiovascular mortality. From
the other two DTS components, the angina index was
not predictive of cardiovascular death in either popu-
lation; however, maximal STD was statistically signiﬁ-
cant in the KIHD study population. The results are
unequivocal in demonstrating that the DTS does not
provide any prognostic information independent of its
components.
This is the ﬁrst study to assess the prognostic value
of the DTS with the standard bicycle ergometer. A pre-
vious study with a limited number of participants
(n¼ 211) was conducted to compare the bicycle ergom-
eter in the supine position and the treadmill test when
assessing the value of the DTS.15 The use of the supine
bicycle ergometer instead of the treadmill led to a lower
maximal workload and METs level.15 This was a
reason that patients got lower DTS results and thus
they were mostly classiﬁed into higher risk categories.
There are several possible explanations as to why
BMI, smoking status and diabetes were associated
with outcome in the KIHD study but not in
FINCAVAS patients. First, the study populations
were quite diﬀerent. In the FINCAVAS cohort,
patients were referred for an exercise test due to clinical
reasons, whereas in the KIHD study, participants were
a randomly selected population-based sample of men.
The KIHD study included middle-aged men based on a
genetically and ethnically homogeneous population
from eastern Finland, an area previously known for
its high prevalence and incidence of cardiometabolic
diseases. In addition, it is possible that the assessment
methods of baseline characteristics and risk factors
inﬂuenced the observed ﬁndings. Finally, the KIHD
study data had an essentially longer follow-up than
the other dataset, granting the risk factors more time
to cause clinical events and cardiovascular mortality.
General diﬀerences between treadmill and standard
bicycle ergometer exercise testing have been studied
earlier, and patients seem to get 10–20% lower maximal
METs if they are not accustomed to cycling,16 possibly
because muscle fatigue prevents them from reaching
their VO2max.
When the DTS was originally developed for tread-
mill exercise testing, ST-deviation was the most
Table 2. Cox regression survival analysis of the DTS as tertiles, its components and covariates, cardiovascular-mortality as an
endpoint.
FINCAVAS KIHD
95% CI 95% CI
HR Lower Upper P value HR Lower Upper P value
DTS (3rd vs. 1st tertile) 1.149 0.604 2.185 0.672 0.900 0.677 1.195 0.466
METs 0.799 0.726 0.88 <0.001 0.821 0.767 0.879 <0.001
STD 1.042 0.869 1.251 0.656 1.209 1.012 1.444 0.036
Angina 0.757 0.571 1.003 0.053 1.057 0.863 1.295 0.592
Age 1.034 1.018 1.05 <0.001 1.068 1.044 1.094 <0.001
Sex 2.929 1.985 4.323 <0.001
BMI 0.999 0.964 1.035 0.965 1.058 1.029 1.087 <0.001
CAD 0.952 0.69 1.313 0.763 1.403 1.138 1.731 0.002
b-Blocker 1.387 0.935 2.057 0.104 1.379 1.109 1.715 0.004
Diabetes 1.216 0.823 1.796 0.327 2.018 1.509 2.700 <0.001
Smoking 1.183 0.832 1.681 0.349 2.199 1.823 2.652 <0.001
HR: hazard ratio; DTS: Duke treadmill score; METs: metabolic equivalents of tasks; STD: maximal ischaemic ST-segment depression during exercise;
Angina: non-limiting (FINCAVAS) and limiting (FINCAVAS and KIHD) angina during exercise; BMI: body mass index; CAD: diagnosed coronary artery
disease.
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powerful prognostic variable, and adding angina and
exercise time increased prognostic power.3 Exercise
capacity (METs) has been repeatedly validated to be
the single most powerful prognostic marker predicting
cardiovascular mortality17–20 and major cardiovascular
events.21 The American Heart Association recently
made a statement that cardiorespiratory ﬁtness should
be assessed routinely in clinical practice.22 In a previous
study, classic cardiovascular risk factors including dia-
betes, hypertension, obesity and smoking, were linked
to decreased exercise capacity.23 In a cohort of middle-
aged men with more than 40 years of follow-up, low
exercise capacity led to increased overall mortality
rates, independent of smoking, blood pressure and
serum cholesterol.24 A large longitudinal study of
Swedish adolescent men found that poor exercise cap-
acity was also associated with a greater risk of incident
heart failure.25 These examples outline the independent
prognostic importance of exercise capacity. In contrast,
the prognostic signiﬁcance of ST-deviation and angina
is still unclear, despite the fact that the diagnostic
power of both ST-segment changes and angina is well
established.26–29
The relative importance of each of the DTS compo-
nents probably depends largely on the population. The
study population from which the DTS was initially
derived had a high probability of CAD, conﬁrmed
by consequent coronary catheterisation, whereas most
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Figure 1. Adjusted Cox regression survival analysis according to Duke treadmill score risk tertiles in both cohorts, cardiovascular
mortality as an endpoint; (a) and (c) without the components of the DTS; (b) and (d) with the components.
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of the later studies have consisted of patients referred
for exercise testing because of a milder suspicion of
CAD. This could partially explain the shift of the best
prognostic marker from ST-deviation to exercise
capacity.
Whether combining the three components into the
DTS yields additional prognostic information in com-
parison to using the components separately has not
been well explored. Previously, using multivariable ana-
lyses in assessing the prognosis of patients has
enhanced the prognostic power compared to analysing
independent variables other than the DTS compo-
nents.19,30,31 In these studies, the analysed variables
were heart rate recovery, T-wave alternans and
METs. This supplementary prognostic information
may have been due to the diﬀerent pathophysiological
bases assessed by diﬀerent variables. In the DTS, there
are two variables indicating myocardial ischaemia
which may not be helpful.
The strength of this study is the usage of two inde-
pendent large prospective datasets and the assessment
of a comprehensive range of potential covariates. The
follow-up of the KIHD study is particularly long; how-
ever, the study is limited by the absence of female par-
ticipants. Data on angina that did not limit exercise was
not considered in the original KIHD study setting. The
strengths of FINCAVAS are a large population and
electronically saved beat-to-beat ECG data.
Measuring exercise capacity as METs may have its
weaknesses regarding patients’ age and fat-free
mass.32–34 Neither study takes into account the changes
in patient characteristics and treatment during the
follow-up period. There can be residual confounders
aﬀecting cardiovascular mortality in addition to covari-
ates, which we accounted for. Naturally, we cannot
draw causal inferences from observational studies.
In conclusion, the DTS seemed to be predictive of
cardiovascular death for patients who underwent
bicycle exercise testing in two diﬀerent populations.
However, when adjusted with its components, the pre-
dictive power of the DTS disappeared, as exercise cap-
acity proved to be a superior predictor of fatal
cardiovascular outcomes. More studies are needed to
conﬁrm our ﬁndings using bicycle exercise testing.
Measuring and categorising exercise capacities should
be further cultivated. Future research should also con-
centrate on developing more accurate multivariable
prognostic scores which take into account more versa-
tile underlying pathophysiological bases.
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